TIGIT up-regulation has been observed in various malignancies, including melanoma, breast cancer, non-small-cell lung carcinoma (NSCLC); indeed TIGIT expression on peripheral blood CD8+ T cells of various cancer patients has been associated with metastases and poor survival 64. Here, TIGIT is linked to melanoma.